We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$794M
Cap. Flow
+$588M
Cap. Flow %
3.81%
Top 10 Hldgs %
11.65%
Holding
3,018
New
218
Increased
954
Reduced
767
Closed
228

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$67.6M
2
SBUX icon
Starbucks
SBUX
+$63.1M
3
HLT icon
Hilton Worldwide
HLT
+$44.5M
4
META icon
Meta Platforms (Facebook)
META
+$44.3M
5
HOG icon
Harley-Davidson
HOG
+$43.2M

Sector Composition

Rank Sector Weight
1 Technology 15.53%
2 Healthcare 14.16%
3 Financials 11.14%
4 Industrials 10.83%
5 Consumer Discretionary 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWW icon
276
W.W. Grainger
GWW
$65.3B
$17.8M 0.12%
76,166
-2,998
-4% -$628K
CHD icon
277
Church & Dwight Co
CHD
$23.1B
$17.5M 0.11%
379,498
+68,342
+22% +$2.98M
RPM icon
278
RPM International
RPM
$13.7B
$17.2M 0.11%
363,160
-3,150
-0.9% -$130K
NJR icon
279
New Jersey Resources
NJR
$6.06B
$17.1M 0.11%
469,298
-71,472
-13% -$2.48M
ACWX icon
280
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$17M 0.11%
430,916
-106,127
-20% -$3.97M
LKFN icon
281
Lakeland Financial Corp
LKFN
$1.52B
$17M 0.11%
556,284
+20,274
+4% +$587K
SCSC icon
282
Scansource
SCSC
$1.12B
$16.8M 0.11%
415,129
-32,591
-7% -$1.14M
CMS icon
283
CMS Energy
CMS
$23.1B
$15.7M 0.1%
370,997
+266,680
+256% +$10.4M
AMAG
284
DELISTED
AMAG Pharmaceuticals
AMAG
$15.6M 0.1%
667,163
+47,997
+8% +$1.14M
AVGO icon
285
Broadcom
AVGO
$1.82T
$15.6M 0.1%
1,008,470
-30,290
-3% -$410K
WBA
286
DELISTED
Walgreens Boots Alliance
WBA
$15.6M 0.1%
184,936
-231,744
-56% -$18.5M
VTI icon
287
Vanguard Total Stock Market ETF
VTI
$654B
$15.4M 0.1%
147,122
-13,412
-8% -$1.33M
DD icon
288
DuPont de Nemours
DD
$18.6B
$15.4M 0.1%
119,564
+6,386
+6% +$765K
HMN icon
289
Horace Mann Educators
HMN
$2.1B
$15.3M 0.1%
483,516
+17,658
+4% +$542K
BCR
290
DELISTED
CR Bard Inc.
BCR
$15.2M 0.1%
75,225
-3,469
-4% -$655K
AOS icon
291
A.O. Smith
AOS
$8.38B
$15M 0.1%
393,308
+40,898
+12% +$1.43M
SHW icon
292
Sherwin-Williams
SHW
$78.3B
$14.6M 0.09%
154,074
+6,810
+5% +$596K
GLW icon
293
Corning
GLW
$126B
$14.5M 0.09%
696,463
+199,742
+40% +$3.7M
IT icon
294
Gartner
IT
$9.41B
$14.2M 0.09%
158,901
-43,665
-22% -$3.69M
OXY icon
295
Occidental Petroleum
OXY
$57B
$14.2M 0.09%
206,986
+2,995
+1% +$201K
CPRI icon
296
Capri Holdings
CPRI
$1.77B
$14.2M 0.09%
248,545
+229,084
+1,177% +$11.3M
HII icon
297
Huntington Ingalls Industries
HII
$11.3B
$14.1M 0.09%
102,819
-70,843
-41% -$9.22M
HAL icon
298
Halliburton
HAL
$27.9B
$14M 0.09%
390,618
+162,844
+71% +$5.31M
WSBC icon
299
WesBanco
WSBC
$3.95B
$13.9M 0.09%
468,571
+16,793
+4% +$480K
COP icon
300
ConocoPhillips
COP
$147B
$13.9M 0.09%
344,970
-198,476
-37% -$7.55M

Similar funds

Glenmede Trust's Q1 2016 Portfolio in Review

As of Q1 2016, Glenmede Trust held 3,018 positions worth $15.4B, up 5.4% from $14.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust deployed $588M of net new capital in Q1 2016, opening 218 new positions and adding to 954 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 723,506 shares worth $26M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $50.7M trimmed.

  • Glenmede Trust's largest Q1 2016 buy was Vanguard FTSE Developed Markets ETF: 723,506 shares worth $26M.
  • Glenmede Trust added most to Oracle in Q1 2016, an estimated $67.6M increase.
  • Glenmede Trust's biggest Q1 2016 reduction was Activision Blizzard, cutting an estimated $50.7M.
  • Glenmede Trust fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $50M.
  • Glenmede Trust's ten largest holdings make up 12% of its $15.4B portfolio in Q1 2016.
  • Glenmede Trust opened 218 new positions and closed 228 in Q1 2016.
  • Glenmede Trust's portfolio value rose 5.4% quarter-over-quarter to $15.4B.

Based on Glenmede Trust's 13F filing for Q1 2016, filed 26 Apr 2016.